openPR Logo
Press release

Preclinical Imaging Market With Covid-19 Impact and Market Size, Share, Growth Factors, Competitive Landscape and Regional Forecast 2031

11-04-2022 01:16 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Global Insight Services

Preclinical Imaging Market

Preclinical Imaging Market

Global Preclinical Imaging Market report from Global Insight Services is the single authoritative source of intelligence on Preclinical Imaging Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

Preclinical imaging uses imaging technology to visualize the internal structure and function of living organisms to study their normal physiology and pathology. This type of imaging is typically used in research settings to study the effects of new drugs or therapies on living tissue and to assess the safety and efficacy of these agents before they are tested in humans.

Read more about Preclinical Imaging Market here: https://www.globalinsightservices.com/reports/preclinical-imaging-market

Key Trends

Preclinical imaging technology is constantly evolving to meet the needs of researchers. The key trends in this field include the development of more sensitive and specific imaging modalities, the use of artificial intelligence (AI) to improve image analysis, and the use of 3D printing to create more realistic models of diseases.

One of the most important trends in preclinical imaging is the development of more sensitive and specific imaging modalities. This is being driven by the need to obtain more accurate data about the progression of diseases and the effectiveness of potential treatments.

Another major trend is the use of AI to improve image analysis. This is particularly important for analyzing large datasets, such as those generated by MRI or CT scans.

Request free sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS24483/

Finally, 3D printing is increasingly used to create more realistic models of diseases. This allows researchers to test potential treatments in a more controlled environment, which can lead to more effective treatments being developed.

Key Drivers

The key drivers of the preclinical imaging market include:

- The increasing use of animal models in drug development.
- The need for more efficient and effective drug development.
- The increasing demand for personalized medicine.

Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS24483/

Market Segments

The preclinical imaging market is segmented by modality, reagants, and region. By modality, the market is classified into optical imaging systems, nuclear imaging systems, and others. Based on reagents, it is bifurcated into MRI contrast agents, ultrasound contrast agents, and others. Region-wise, the market is segmented into North America, Europe, Asia Pacific, and the rest of the World.

Key Players

The preclinical imaging market includes players such as PerkinElmer Inc., Bruker Corporation, Fujifilm Holdings Corporation, Mediso Ltd., MILabs B.V., MR Solutions, Li-Cor Biosciences, Aspect Imaging, TriFoil Imaging, Miltenyi Biotech GmbH, and others.

Purchase your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS24483/

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Preclinical Imaging Market With Covid-19 Impact and Market Size, Share, Growth Factors, Competitive Landscape and Regional Forecast 2031 here

News-ID: 2793116 • Views:

More Releases from Global Insight Services

Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing at 17.5% CAGR | Overall Study Report
Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing …
The Immuno Oncology Drugs Market is rapidly emerging as a transformative segment in the global healthcare industry. These drugs harness the body's immune system to identify and attack cancer cells, offering innovative treatment alternatives to traditional chemotherapy and radiation therapies. Immuno-oncology therapies include monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and cell-based therapies such as CAR-T cells. The growth of this market is primarily driven by advancements in biotechnology, an improved
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Overall Study Report
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Ove …
The GLP 1 Market is experiencing unprecedented growth, fueled by the rising prevalence of type 2 diabetes and obesity globally. GLP-1, or glucagon-like peptide-1 receptor agonists, represents a groundbreaking therapeutic class that improves insulin secretion, reduces glucagon production, and slows gastric emptying. These mechanisms not only enhance glycemic control but also support weight management, making GLP-1 therapies a preferred choice among healthcare providers and patients alike. Over the years, the
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAGR | Key Players: EasyMile, Navya, Aurrigo
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAG …
Market Overview Autonomous Bus Market is revolutionizing the future of urban mobility through advanced automation technologies. Valued at $2.1 billion in 2024, the market is projected to reach $11.6 billion by 2034, expanding at a strong CAGR of 18.8%. This market focuses on the development and deployment of self-driving buses equipped with cutting-edge sensors, artificial intelligence, and vehicle-to-everything (V2X) communication systems. These buses are designed to improve road safety, enhance passenger
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | Key Players: Apollo Tyres, Nokian Tyres, Hankook Tire
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | …
Market Overview Automotive Tire Market is experiencing remarkable growth as the industry embraces innovation, sustainability, and digital transformation. Valued at $406 billion in 2024, the market is projected to soar to $976.7 billion by 2034, reflecting a CAGR of 9.2%. This expansion is primarily driven by the surge in global vehicle production, growing consumer preference for durable and high-performance tires, and the increasing adoption of smart tire technologies. The Automotive Tire

All 5 Releases


More Releases for Preclinical

Driving Preclinical CRO Market Growth in 2025: The Role of Surging Demand For Pr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Preclinical CRO Market Size Growth Forecast: What to Expect by 2025? In recent times, there has been a significant increase in the size of the preclinical CRO market. The market will develop from being worth $5.7 billion in 2024 to achieving a value of $6.26 billion the following year,
DLL3 Inhibitors in Preclinical and Clinical Studies
Delta-Like Ligand 3 (DLL3) inhibitors have shown significant promise in preclinical and clinical studies, particularly for the treatment of aggressive cancers such as small cell lung cancer (SCLC) and neuroendocrine tumors. The selective expression of DLL3 in these malignancies makes it an attractive target for therapeutic intervention. This article explores the development and progress of DLL3 inhibitors in preclinical and clinical studies, highlighting their potential in modern oncology. Download Report: https://www.kuickresearch.com/report-dll3-targeted-therapies-dll3-cancer-therapies-dll3-protien-dll3-cancer-drugs-delta-like-ligand-3-dll3-gene-dll3-expression-dll3-amgen-dll3-inhibitor DLL3
Preclinical CRO Market Size Forecast Between 2023-2032
The global market for Preclinical Contract Research Organizations (CROs) has witnessed substantial growth in recent years, driven by increasing outsourcing of preclinical research activities by pharmaceutical and biotechnology companies. In 2022, the market size reached USD 5.2 Billion and is projected to grow to USD 10.7 Billion by 2032, with a compound annual growth rate (CAGR) of 7.6% from 2023 to 2032. This article delves into the current trends, drivers,
Preclinical Imaging Market Opportunity | Size | Research Report
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲-  Preclinical Imaging Market was valued at USD 748.18 Million in 2023 and is projected to reach USD 1,109.10 Million by 2030, growing at a CAGR of 5.0% from 2024 to 2030. The preclinical imaging market is being significantly driven by advancements in imaging modalities, such as MRI, PET, SPECT, CT, and optical imaging. These technologies provide researchers with non-invasive ways to visualize and study biological processes at the
Preclinical Imaging Market - Transforming Research with Precision Imaging: Precl …
Newark, New Castle, USA: The "Preclinical Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Preclinical Imaging Market: https://www.growthplusreports.com/report/preclinical-imaging-market/7673 This latest report researches the industry structure, sales, revenue,
Preclinical Imaging Market - Unlocking Clarity, Preserving Scientific Excellence …
Newark, New Castle, USA - new report, titled Preclinical Imaging Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Preclinical Imaging market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Preclinical Imaging market. The report offers an overview of the market, which